RayzeBio, Inc. (NASDAQ:RYZB) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Christy Oliger Other companies: Zenas BioPharma, Inc. (Director · Since at least Aug 13, 2026); Bicara Therapeutics Inc. (Director · Since at least Jul 28, 2026); Nuvalent, Inc. (Director · Since at least Jun 18, 2025); LAVA Therapeutics NV (Director · Since at least Jan 1, 2025); Vera Therapeutics, Inc. (Director · Since at least Jun 7, 2024); Replimune Group, Inc. (Director · Since at least Dec 1, 2021); Karyopharm Therapeutics Inc. (Director · Since at least Aug 28, 2020); Sierra Oncology Inc (Director · Jun 2, 2021 – Jul 1, 2022 · Past); Reata Pharmaceuticals Inc (Director · Apr 15, 2021 – Sep 26, 2023 · Past) | Director · Sep 14, 2023 – Feb 26, 2024 · Past |
| Richard Heyman Other companies: Enliven Therapeutics, Inc. (Director · Since at least Feb 23, 2023); PMV Pharmaceuticals, Inc. (Director · Since at least Sep 24, 2020); ORIC Pharmaceuticals, Inc. (Chairman · Since at least Apr 23, 2020); Kineta Inc. (Director · Dec 22, 2020 – Jun 2, 2021 · Past); Metacrine Inc (Director · Sep 15, 2020 – May 18, 2022 · Past); Tango Therapeutics, Inc. (Director · Sep 2, 2020 – Sep 2, 2020 · Past); Gritstone bio, Inc. (Director · Sep 27, 2018 – Jun 17, 2022 · Past) | Director · Sep 14, 2023 – Feb 26, 2024 · Past |
| Angie You Other companies: Attovia Therapeutics, Inc. (Director · Since at least Aug 4, 2026); ORIC Pharmaceuticals, Inc. (Director · Since at least Nov 9, 2021); Sierra Oncology Inc (Chief Bus. & Strat. Officer · Jul 15, 2015 – Mar 6, 2018 · Past) | Director · Sep 14, 2023 – Feb 26, 2024 · Past |
| Mary Tagliaferri Other companies: ADARx Pharmaceuticals, Inc. (Chief Medical Officer and SVP at Nektar Therapeutics · Since at least Sep 24, 2026); Y mAbs Therapeutics (Director · Feb 29, 2024 – Jun 11, 2024 · Past); Enzo Biochem Inc (Director · Nov 17, 2020 – Jan 31, 2024 · Past) | Director · Sep 14, 2023 – Feb 26, 2024 · Past |
| Susan Moran Other companies: Crescent Biopharma, Inc. (Director · Since at least Jun 13, 2025); Tyra Biosciences, Inc. (Board member · Since at least May 7, 2024); BioAtla, Inc. (Director · Since at least Dec 15, 2020) | CHIEF MEDICAL OFFICER · Sep 14, 2023 – Feb 26, 2024 · Past |
| Maha Katabi Other companies: Vera Therapeutics, Inc. (Director · May 13, 2021 – May 14, 2025 · Past); Jade Biosciences, Inc. (Director · Feb 1, 2021 – Jun 5, 2024 · Past) | Director · Sep 14, 2023 – Feb 26, 2024 · Past |
| Yi Larson Other companies: Olema Pharmaceuticals, Inc. (Director · Since at least Apr 5, 2021); Turning Point Therapeutics Inc (EVP & Chief Financial Officer · Aug 26, 2019 – Feb 8, 2021 · Past) | Director · Sep 14, 2023 – Feb 26, 2024 · Past |
| Arvind Kush Other companies: Inhibikase Therapeutics, Inc. (Director · Since at least Oct 21, 2024) | CHIEF FINANCIAL OFFICER · Sep 14, 2023 – Feb 26, 2024 · Past |
| Kenneth Song Other companies: Freenome, Inc. (Director · Jun 11, 2024 – Jun 11, 2024 · Past) | PRESIDENT AND CHIEF EXECUTIVE, Director · Sep 14, 2023 – Feb 26, 2024 · Past |